Cough Suppressant Drugs Market is accounted for US$ 1100.4 Mn in 2020 with 3.7% CAGR by 2027 | Global Analysis by Size, Growth, Trends, Development Activities by Top Players And Country Level Analysis

Overview:

A cough is the body’s way of responding when something irritates the throat or airways. Cough suppressant drugs, such as Codeine, Dextromethorphan, Pholcodine, Benzonatate, Butamirate, and Noscapine, are used to relieve the symptoms of cough. These drugs help reduce the activity of cough reflex and suppresses the urge to cough.

Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/2427

Driver:

Increasing launches and approvals of new suppressants is expected to propel the growth of the global cough suppressant drugs market. For example, in 2017, Aurobindo Pharma received final nod from the US health regulator for its Guaifenesin extended-release tablets used as expectorant. According to the company, these tablets help to loosen phlegm, and thin bronchial secretions to rid bronchial passageways of bothersome mucus and make coughs more productive.

Restraints;

Stringent rules and regulations regarding the use of cough suppressant drugs are expected to hinder growth of the market during the forecast period. For example, in January 2018, the Food and Drug Administration (FDA) changed labels on such medication to limit their use and provide additional safety information. According to the new regulations, children under 18 should not use prescription cough and cold medicines containing codeine or hydrocodone.

Moreover, the Colorado and Health Canada banned the sales of non-prescription drugs containing the cough suppressant dextromethorphan and codeine, respectively.

Key Players:

Key players involved in the global cough suppressant drugs market are GlaxoSmithKline plc, Aurobindo Pharma Ltd, Amneal Pharmaceuticals LLC, Taro Pharmaceutical Industries Ltd., Mayne Pharma Inc., Acella Pharmaceuticals LLC, Aytu BioScience, Inc, Pfizer Inc, Tris Pharma Inc., Vernalis plc., and Perrigo Company plc.

In 2012, Vernalis and Tris Pharma signed an agreement to develop and commercialize multiple novel products in the U.S. prescription cough/cold market.

Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/2427

Table of Content

Global Cough Suppressant Drugs Market Research Report
Section 1: Global Cough Suppressant Drugs Industry Overview
Section 2: Global Economic Impact on Cough Suppressant Drugs Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Cough Suppressant Drugs Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Cough Suppressant Drugs Market Forecast

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837